Maravai LifeSciences Holdings Inc
MRVI2.870USD
-0.020-0.69%
收盤 11/07, 16:00（美東）報價延遲15分鐘
415.05M總市值
虧損本益比TTM
關於 Maravai LifeSciences Holdings Inc 公司
Maravai LifeSciences Holdings, Inc. 是一家生命科學公司，提供關鍵產品以促進藥物療法、診斷和新型疫苗的開發並支持人類疾病的研究。其部門包括核酸生產部門和生物製劑安全測試部門。核酸生產部門專注於製造和銷售高度改良的核酸產品，以滿足客戶的研究、治療和疫苗計劃的需求。該部門的業務部門包括 TriLink Discovery、TriLink GMP、Glen Research 和 Alphazyme。生物製劑安全測試部門專注於製造和銷售生物製劑安全和雜質測試以及檢測開發服務，客戶可在生物藥物製造活動中使用這些服務。該部門的業務由 Cygnus Technologies 組成。它爲各種公司提供服務，包括生物製藥、疫苗、診斷以及細胞和基因治療。
Maravai LifeSciences Holdings Inc簡介
公司代碼MRVI
公司名稱Maravai LifeSciences Holdings Inc
上市日期Nov 20, 2020
CEOMr. Bernd Brust
員工數量570
證券類型Ordinary Share
年結日Nov 20
公司地址10770 Wateridge Circle Suite 200
城市SAN DIEGO
上市交易所NASDAQ Global Select Consolidated
國家United States of America
郵編92121
電話18585460004
網址https://www.maravai.com/
公司代碼MRVI
上市日期Nov 20, 2020
CEOMr. Bernd Brust
Maravai LifeSciences Holdings Inc公司高管
名稱
名稱/職務
職務
持股
持股變動
Mr. Bernd Brust
Mr. Bernd Brust
Chief Executive Officer, Director
Chief Executive Officer, Director
2.00M
--
Mr. Rajesh J. (Raj) Asarpota
Mr. Rajesh J. (Raj) Asarpota
Chief Financial Officer
Chief Financial Officer
500.00K
--
Mr. Kurt Oreshack
Mr. Kurt Oreshack
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
439.87K
+196.03%
Mr. Robert Andrew (Andy) Eckert
Mr. Robert Andrew (Andy) Eckert
Independent Chairman of the Board
Independent Chairman of the Board
365.89K
+172.22%
Ms. Christine Dolan
Ms. Christine Dolan
Executive Vice President, General Manager - Cygnus Technologies
Executive Vice President, General Manager - Cygnus Technologies
335.06K
+0.72%
Ms. Susannah Gray
Ms. Susannah Gray
Independent Director
Independent Director
169.91K
+110.36%
Mr. Luke Joseph Marker
Mr. Luke Joseph Marker
Director
Director
138.06K
+182.23%
Mr. Gregory T. (Greg) Lucier
Mr. Gregory T. (Greg) Lucier
Independent Director
Independent Director
75.77K
-54.05%
Dr. John A. Deford, Ph.D.
Dr. John A. Deford, Ph.D.
Independent Director
Independent Director
--
--
Mr. Sean L. Cunningham
Mr. Sean L. Cunningham
Director
Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Bernd Brust
Mr. Bernd Brust
Chief Executive Officer, Director
Chief Executive Officer, Director
2.00M
--
Mr. Rajesh J. (Raj) Asarpota
Mr. Rajesh J. (Raj) Asarpota
Chief Financial Officer
Chief Financial Officer
500.00K
--
Mr. Kurt Oreshack
Mr. Kurt Oreshack
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
439.87K
+196.03%
Mr. Robert Andrew (Andy) Eckert
Mr. Robert Andrew (Andy) Eckert
Independent Chairman of the Board
Independent Chairman of the Board
365.89K
+172.22%
Ms. Christine Dolan
Ms. Christine Dolan
Executive Vice President, General Manager - Cygnus Technologies
Executive Vice President, General Manager - Cygnus Technologies
335.06K
+0.72%
Ms. Susannah Gray
Ms. Susannah Gray
Independent Director
Independent Director
169.91K
+110.36%
收入明細
單位: USD更新時間: 10月6日 週一
單位: USD更新時間: 10月6日 週一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
暫無數據
地區USD
名稱
營收
佔比
North America
30.64M
64.64%
Europe, the Middle East and Africa
8.39M
17.71%
Asia Pacific
8.16M
17.21%
Latin and Central America
327.00K
0.69%
業務
地區
暫無數據
股東統計
更新時間: 8月16日 週六
更新時間: 8月16日 週六
持股股東
股東類型
持股股東
持股股東
佔比
GTCR Golder Rauner, LLC
13.93%
12 West Capital Management, L.P.
8.65%
BlackRock Institutional Trust Company, N.A.
5.81%
Braidwell LP
5.77%
The Vanguard Group, Inc.
4.93%
其他
60.91%
持股股東
持股股東
佔比
GTCR Golder Rauner, LLC
13.93%
12 West Capital Management, L.P.
8.65%
BlackRock Institutional Trust Company, N.A.
5.81%
Braidwell LP
5.77%
The Vanguard Group, Inc.
4.93%
其他
60.91%
股東類型
持股股東
佔比
Investment Advisor
27.99%
Hedge Fund
26.51%
Investment Advisor/Hedge Fund
16.20%
Private Equity
13.93%
Individual Investor
6.19%
Corporation
4.75%
Research Firm
3.82%
Pension Fund
0.20%
Bank and Trust
0.16%
其他
0.26%
機構持股
更新時間: 10月1日 週三
更新時間: 10月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
518
128.65M
88.93%
-44.43M
2025Q2
560
144.27M
100.21%
-25.80M
2025Q1
589
133.65M
92.84%
-44.45M
2024Q4
580
144.56M
101.93%
-33.57M
2024Q3
603
148.21M
104.79%
-33.05M
2024Q2
611
152.09M
114.44%
-19.50M
2024Q1
609
139.87M
105.40%
-26.88M
2023Q4
621
137.21M
103.78%
-26.31M
2023Q3
641
137.53M
104.23%
-17.92M
2023Q2
646
129.68M
98.32%
-22.48M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
GTCR Golder Rauner, LLC
20.15M
13.93%
--
--
Jun 30, 2025
12 West Capital Management, L.P.
12.52M
8.65%
--
--
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
8.41M
5.81%
+52.73K
+0.63%
Jun 30, 2025
Braidwell LP
8.35M
5.77%
--
--
Jun 30, 2025
The Vanguard Group, Inc.
9.38M
6.48%
-2.26M
-19.38%
Jun 30, 2025
Hudson View Capital LLC
6.87M
4.75%
+6.87M
--
May 21, 2025
Mackenzie Investments
6.07M
4.2%
-44.32K
-0.72%
Jun 30, 2025
Renaissance Technologies LLC
4.19M
2.89%
+75.50K
+1.84%
Jun 30, 2025
Mirabella Financial Services LLP
3.75M
2.59%
+10.05K
+0.27%
Jun 30, 2025
Point72 (DIFC) Ltd
3.72M
2.57%
+2.16M
+138.99%
Jun 30, 2025
查看更多
持股ETF
更新時間: 11月6日 週四
更新時間: 11月6日 週四
機構名稱
佔比
Global X Genomics & Biotechnology ETF
0.39%
ProShares Ultra Nasdaq Biotechnology
0.04%
Invesco Nasdaq Biotechnology ETF
0.04%
iShares Biotechnology ETF
0.03%
Invesco RAFI US 1500 Small-Mid ETF
0.03%
iShares Russell 2000 Value ETF
0.02%
Schwab U.S. Small-Cap ETF
0.01%
iShares Russell 2000 ETF
0.01%
Proshares Ultra Russell 2000
0.01%
ProShares Hedge Replication ETF
0.01%
查看更多
Global X Genomics & Biotechnology ETF
佔比0.39%
ProShares Ultra Nasdaq Biotechnology
佔比0.04%
Invesco Nasdaq Biotechnology ETF
佔比0.04%
iShares Biotechnology ETF
佔比0.03%
Invesco RAFI US 1500 Small-Mid ETF
佔比0.03%
iShares Russell 2000 Value ETF
佔比0.02%
Schwab U.S. Small-Cap ETF
佔比0.01%
iShares Russell 2000 ETF
佔比0.01%
Proshares Ultra Russell 2000
佔比0.01%
ProShares Hedge Replication ETF
佔比0.01%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
